| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -3K | 100% | $2.01 | -$6.02K |
| Net | -1 | -3K | -100% | -$6.02K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin S. Sr. Boyle | Chief Executive Officer, Director | $112K | Sep 1, 2023 | ||
| Jaime Vieser | Director | $51.8K | -$6.02K | -10.4% | Dec 31, 2024 |
| Raffaele Baffa | Chief Medical Officer | $39.4K | May 17, 2021 | ||
| Heidi Hagen | Director | $20.5K | Sep 2, 2021 | ||
| Christopher Bowden | Director | $6.2K | Jun 22, 2022 | ||
| Michael Wong | Vice President, Finance | Mar 15, 2023 | |||
| Drew Deniger | Vice President, Research and Development | Mar 15, 2023 | |||
| Abhishek K. Srivastava | Vice President, Technical Operations | Mar 15, 2023 | |||
| Robert Hofmeister | Director | Jun 6, 2024 | |||
| Melinda Lackey | Legal & Administration | Aug 14, 2024 | |||
| Eleanor De Groot | EVP, Operations | Mar 30, 2022 | |||
| Ferdinand Groenewald | VP, Finance | Aug 14, 2024 | |||
| Dale Curtis Hogue Jr. | Interim CEO, Director | Jan 20, 2024 | |||
| James Huang | Director | Jun 6, 2023 | |||
| Mary Thistle | Director | Jun 6, 2023 | |||
| Holger Weis | Director | Jun 6, 2024 | |||
| Robert W. Postma | Director | Jun 6, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|